Prof. Antoaneta Tsvetkova, PhD (Economics) is a Professor of Social Pharmacy and Pharmacoeconomics and Director of the Medical College at the Medical University of Varna, Bulgaria. Her research interests include pharmacoeconomics, health technology assessment (HTA), health economics, and pharmaceutical policy. She is the author of over 100 scientific publications, two monographs, and co-author of several textbooks and handbooks. She has led and participated in national and international research projects focused on public health, pharmaceutical care, and access to innovative therapies. Prof. Tsvetkova has specialized in HTA, pricing and reimbursement, and healthcare economics. She teaches courses in medical devices, social pharmacy, OTC products, pharmaceutical legislation, and health economics. She is an active member of ISPOR Bulgaria, the Bulgarian Public Health Society, and expert working groups at the national level. Her academic focus is aimed at improving pharmaceutical care, promoting the integration of pharmacoeconomic approaches into health system management, and supporting evidence-based policy decisions.
Prof. Antoaneta Tsvetkova, PhD (Economics) is a Professor of Social Pharmacy and Pharmacoeconomics and Director of the Medical College at the Medical University of Varna, Bulgaria. Her research interests include pharmacoeconomics, health technology assessment (HTA), health economics, and pharmaceutical policy. She is the author of over 100 scientific publications, two monographs, and co-author of several textbooks and handbooks. She has led and participated in national and international research projects focused on public health, pharmaceutical care, and access to innovative therapies. Prof. Tsvetkova has specialized in HTA, pricing and reimbursement, and healthcare economics. She teaches courses in medical devices, social pharmacy, OTC products, pharmaceutical legislation, and health economics. She is an active member of ISPOR Bulgaria, the Bulgarian Public Health Society, and expert working groups at the national level. Her academic focus is aimed at improving pharmaceutical care, promoting the integration of pharmacoeconomic approaches into health system management, and supporting evidence-based policy decisions.